21Shares Files for Injective ETF: Big Moves as DeFi Gets Its Day in the Sun

by

21Shares files with the SEC for a spot Injective ETF to offer direct INJ exposure as institutional interest in DeFi continues to grow.

21Shares, in an attempt to make DeFi mainstream, has submitted a proposal to the U.S. Securities and Exchange Commission (SEC) for a spot Injective (INJ) exchange-traded fund (ETF). Hold on to your hats, folks-this isn’t just another half-hearted crypto experiment.

The fund would offer direct exposure to INJ through cold, hard (and cold-stored) tokens, catering to a growing institutional demand for decentralized assets. This move comes amidst an uptick in attention surrounding Injective’s Layer 1 blockchain and its growing list of new friendships with big financial players. Things are heating up, and Injective’s spot on the blockchain stage is no longer just a footnote.

Spot ETF Proposal to Offer Direct INJ Exposure

Ah, yes, the classic spot ETF. 21Shares filed earlier this week, looking to launch an ETF backed by actual INJ tokens, securely tucked away in cold storage. Sounds familiar, right? It’s not far from the Bitcoin and Ethereum ETFs that have already garnered attention in traditional markets. Who doesn’t love a nice, safe, regulated way to dabble in the digital magic?

According to their filing, the fund aims to provide regulated access to Injective’s native asset. No more “maybe” investments or “we’ll see how it goes” vibes. This is the real deal.

BREAKING: 21Shares just filed for a new ETF.

This is a major signal of growing institutional interest, making Injective one of the few digital assets with multiple ETF products in progress. Among the world’s largest exchange-traded product issuers, it’s on the move.

– Injective (@injective)

Injective’s official X account (yes, we’re calling it that now) proudly shared this news, signaling to the market that things are happening-and yes, they’re happening fast.

Analysts have noted that this move is a direct response to the increasing demand from institutions for Layer 1 protocols that can support DeFi applications. Canary Capital also tried to get in on the action with its own INJ ETF filing in July, but 21Shares brings a bit more gravitas to the table, thanks to its already established lineup of ETFs. Bigger name, bigger buzz, right?

Injective’s Ecosystem and Institutional Growth

Injective isn’t just another blockchain with lofty dreams. It’s a Layer 1 blockchain built for decentralized finance, offering the kind of high-speed performance and low transaction costs that traders and developers would gladly sell their souls for. Okay, maybe not their souls, but you get the point.

With delegated proof-of-stake (DPoS), Injective handles over 25,000 transactions per second-try keeping up with that kind of speed. And, if that’s not enough, the network is eyeing Ethereum Virtual Machine (EVM) compatibility and tools to bring real-world assets into its ecosystem. Big things are brewing.

Backed by big names like Google Cloud and BitGo, Injective continues to expand its reach, making waves across the DeFi space. Their governance initiatives through the Injective Council? Yeah, they’re making those too.

This week, the US government is continuing to move onchain, the SEC opened its comment period for the ETF launch and the Injective community took over Japan.

Dive into all the latest news around the Injective ecosystem over the last few days.

Major Announcements→…

– Injective (@injective)

As token adoption increases, institutions are hopping on the Injective bandwagon. This ETF proposal by 21Shares is, in some circles, considered a regulated path for investors to experience the thrill of INJ exposure without the whole “wild west” feeling.

INJ Price Holds Steady Amid Filing News

INJ has been trading at around $8.75 since the ETF announcement-yes, that’s still way off its $52.75 all-time high in March, but we’re not crying about it. It’s holding its own, even with the broader market acting like a rollercoaster. The token hasn’t dipped below $8.00, and traders are keeping an eye on it, ready to pounce on any sudden moves.

Pineapple Financial recently tossed $100 million into digital assets, including INJ, showing that the institutional crowd is getting a little more comfortable with this whole “crypto” thing. The ETF proposal hasn’t caused a massive price surge, but who knows? Analysts see this as the first step toward a real market integration-because, as we all know, money talks. Loudly.

With the SEC still reviewing, who knows what this will mean for the future pricing? The waiting game continues.

Read More

2025-10-21 16:51